Physician profile
Joseph E Watson
NPI 1336140664
$1,881.28
in general payments reported to CMS, 2019-2025
22 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $199 · 2021: $417 · 2022: $334 · 2023: $60.19 · 2024: $217 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $670.61 | 2021-2025 | Qulipta, Ubrelvy |
| Amgen INC. | $168.50 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $162.28 | 2019-2022 | |
| Allergan, INC. | $119.96 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $100.03 | 2021-2022 | |
| Bioventus LLC | $83.33 | 2025 | Stimrouter Implantable Kit |
| Arbor Pharmaceuticals, INC. | $79.99 | 2019-2021 | |
| Glaxosmithkline, LLC. | $69.72 | 2019-2022 | |
| Novo Nordisk INC | $69.55 | 2019-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $59.59 | 2019-2021 | |
| Astellas Pharma US INC | $57.60 | 2024 | Veozah |
| Lilly USA, LLC | $53.31 | 2019-2021 | |
| Sanofi Pasteur INC. | $30.51 | 2019 | |
| Pfizer INC. | $29.72 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $22.38 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.64 | 2025 | Inceptiv |
| Hologic Sales and Service, LLC | $15.55 | 2024 | Thinprep 2000 Processor |
| Genentech USA, INC. | $15.26 | 2020 | |
| Abbott Laboratories | $14.96 | 2022 | |
| Eisai INC. | $14.94 | 2023 | |
| Greenwich Biosciences, INC. | $14.44 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.